Shanghai - Delayed Quote CNY

Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)

Compare
23.82 +0.34 (+1.45%)
At close: October 22 at 3:00 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Cash Flows from Used in Operating Activities Direct
237,525.32
199,353.55
119,690.34
70,912.50
58,405.52
--
Operating Cash Flow
237,525.32
199,353.55
119,690.34
70,912.50
58,405.52
--
Investing Cash Flow
-175,343.95
-447,715.41
-324,507.04
-642,447.04
-420,834.90
--
Financing Cash Flow
38,820.37
143,621.14
-56,892.17
57,755.76
-93,044.87
--
End Cash Position
280,181.08
227,220.50
333,328.20
595,789.06
1,109,721.55
--
Capital Expenditure
-105,773.75
-100,913.08
-96,310.78
-164,651.18
-50,373.22
--
Issuance of Debt
115,306.60
147,756.37
--
3,196.62
24,953.28
--
Repayment of Debt
-73,042.32
-2,080.41
--
-27,422.23
--
--
Free Cash Flow
131,751.57
98,440.47
23,379.56
-93,738.68
8,032.30
--
12/31/2019 - 9/3/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers